Only recently has the ribosome—one of the oldest molecular machines in evolutionary terms—been recognized as an active ...
A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.
11h
News-Medical.Net on MSNA versatile toolbox sets gold standard for characterizing IRES activity in cellsOnly recently has the ribosome - one of the oldest molecular machines in evolutionary terms - been recognized as an active regulator of gene expression at the level of protein biosynthesis.
15h
The Brighterside of News on MSNBreakthrough mRNA vaccine reinvents pancreatic cancer treatmentLong before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...
StockStory.org on MSN4h
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...
A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
11h
Irish Examiner on MSNCan targeting senescent cells really slow down ageing?Zombie cells are a hot topic in the scientific community, with groundbreaking research being conducted worldwide to find ways ...
Preclinical data with the investigational gene therapy INS1202 show improvements in survival and motor performance in ALS.
Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Cartesian Therapeutics in a report released on Monday, March 17th. Cantor Fitzgerald analyst K. Kluska forecasts that the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results